FATE
Fate Therapeutics Inc
2.40$
+0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -12.2% | -3.2% | -13.1% | +38.5% | +28.2% | +10.2% | +24.0% | +82.1% | +40.8% | +89.5% | +135.2% | +32.9% | +3.7% | -51.0% | |
| – | -9.9% | +902.6% | +56.6% | -1.4% | +32.7% | +13.3% | +74.5% | +176.7% | +76.6% | +76.8% | +44.8% | -44.8% | -4.5% | -39.9% | |
| – | – | – | +65.2% | +18.6% | +21.2% | +37.4% | +36.0% | +153.9% | +76.6% | +21.4% | +38.7% | – | – | – | |
| – | +462.7% | -84.1% | -94.5% | +2,076.5% | +218.9% | +76.5% | -16.3% | +108.7% | -450.9% | – | -1,754.4% | – | -110.2% | – | |
| – | +35,350.0% | -65.6% | +261.5% | +69.8% | -69.5% | +277.5% | +33.5% | +221.1% | -33.3% | +928.1% | -29.9% | -82.7% | -88.1% | +715.5% | |
| – | -454.5% | -66.4% | +270.6% | +69.8% | +174.6% | +147.8% | -95.5% | +33,907.1% | +2.3% | +101.2% | – | -32.4% | -89.2% | +809.9% | |
| – | – | – | – | – | -55.7% | +8,074.7% | – | – | – | – | – | – | – | – | |
| – | – | – | -99.6% | +195.8% | -55.7% | -203.8% | – | -6.3% | +9,749.9% | +74.1% | – | – | – | – | |
| – | – | – | -9.1% | -108.5% | +397.3% | – | -454.9% | +0.0% | – | – | – | – | – | – | |
| – | +134.7% | +263.0% | -69.7% | +93.9% | +62.2% | -17.8% | +196.7% | +6.5% | +88.6% | +60.2% | -98.0% | -99.1% | +117,420.0% | -94.5% | |
| – | – | +1,564.8% | -111.0% | – | +51.5% | -98.6% | +29,540.5% | -189.2% | – | -150.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.